Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging StudyAsit Parikh, Brian G. Feagan, Serap Sankoh et al.|Inflammatory Bowel Diseases|2011Cited by 211
Reductions in Corticosteroid Use in Patients with Ulcerative Colitis or Crohnʼs Disease Treated with VedolizumabBruce E. Sands, Brian G. Feagan, Stephen B. Hanauer et al.|The American Journal of Gastroenterology|2013Cited by 6